Summary
A lump or raised area after a subcutaneous peptide injection is common and usually harmless. Here are the most likely causes — from injection speed to site reaction — and when to be concerned.
The Most Common Cause: A Fluid Wheal
A subcutaneous injection deposits fluid (bacteriostatic water + dissolved peptide) into the layer of tissue between the skin and muscle. This fluid temporarily occupies space that tissue will gradually absorb. The result is often a small raised area — a wheal — at the injection site.
This is normal, expected, and benign. It typically resolves within 30 minutes to a few hours as the fluid is absorbed. It does not indicate a problem with the injection or the compound.
Other Common Causes
Injecting Too Quickly
The faster fluid is injected into subcutaneous tissue, the more visible the wheal. Slow, steady injection — taking 5–10 seconds to depress the plunger for a typical research dose — produces a smaller, faster-resolving lump than rapid injection.
pH of the Solution
Bacteriostatic water has a near-neutral pH, which is appropriate for most peptides. If a compound was reconstituted with a lower-pH diluent (such as 0.6% acetic acid, required for some peptides), the slight acidity can cause a more pronounced local reaction — a burning sensation and more visible wheal. This is not dangerous, but it is uncomfortable and the wheal may take longer to resolve.
Volume
Larger injection volumes create larger wheals. Most peptide research doses are administered in 0.1–0.3 mL. If you are injecting a higher volume, the lump will be proportionally larger.
Lipohypertrophy
Repeatedly injecting into the same spot causes the subcutaneous fat cells at that location to grow thicker and fibrous. This lipohypertrophy creates a persistent, firm lump that does not resolve between injections. Over time it can impair absorption.
The solution is site rotation. Develop a systematic rotation across multiple areas — abdomen, thighs, upper arms — and avoid returning to any single site more than once every 7–10 days.
Cold Solution
Injecting a solution taken directly from the refrigerator causes a more pronounced local reaction than one brought to room temperature first. Remove the vial 10–15 minutes before injection and allow it to reach room temperature.
When to Be Concerned
Contact a medical professional if the injection site shows:
- Increasing redness or warmth beyond 24 hours
- Redness spreading outward from the injection site
- Increasing pain or tenderness (rather than diminishing)
- Pus or discharge
- Fever or systemic symptoms
These signs suggest infection and require prompt evaluation. Infection from subcutaneous injection is uncommon with proper technique and sterile equipment, but it is not impossible.
Improving Technique
To minimise injection site reactions:
- Allow solution to reach room temperature before injecting
- Inject slowly — 5–10 seconds per dose
- Use the shortest appropriate needle for subcutaneous delivery
- Rotate sites systematically and keep a log
- Ensure skin and equipment are clean before injection
- Do not inject into an area that is still raised or sore from a previous injection
Related Topics
Safety & Regulatory Note
While most post-injection lumps are benign and self-resolving, any injection site that becomes increasingly red, warm, hard, or painful over 24–48 hours warrants medical evaluation. Signs of infection should be taken seriously.
References
- 1.Based on manufacturer documentation and published literature on subcutaneous injection technique.
- 2.Hirsch LJ, et al. (2010). Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Current Medical Research and Opinion, 26(6), 1531–1541.
- 3.Frid AH, et al. (2016). New Insulin Delivery Recommendations. Mayo Clinic Proceedings, 91(9), 1231–1255.
